Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$57.6 - $70.59 $402,336 - $493,071
-6,985 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$51.81 - $118.56 $134,706 - $308,256
-2,600 Reduced 27.13%
6,985 $465,000
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $44,404 - $55,791
-400 Reduced 4.01%
9,585 $1.06 Million
Q4 2020

Feb 16, 2021

BUY
$88.75 - $119.95 $44,375 - $59,975
500 Added 5.27%
9,985 $1.19 Million
Q2 2020

Aug 13, 2020

BUY
$84.96 - $118.91 $161,424 - $225,929
1,900 Added 25.05%
9,485 $849,000
Q4 2019

Feb 12, 2020

BUY
$114.37 - $129.46 $11,437 - $12,946
100 Added 1.34%
7,585 $872,000
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $2,125 - $3,128
26 Added 0.35%
7,485 $901,000
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $620,961 - $761,713
7,459 New
7,459 $653,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.